Lorillard
the Second Report to the Ad Hoc Advisory Committee of the Harvard University Tobacco and Health Research Program
Fields
- Author
- Huber, G.L.
- Area
- LEGAL DEPT FILE ROOM
- Alias
- 03750491/03750547
- Type
- REPT, OTHER REPORT
- LIST, LIST
- Named Person
- Abelmann
- Allen, W.
- Alroy, G.
- Arky, R.
- Badger, T.
- Barger, C.A.
- Bing
- Bloch, K.J.
- Brain, J.D.
- Brinton, J.
- Bruderman, I.
- Califano
- Davies, P.
- Drath, D.
- Ellenbogan, M.
- First, M.
- Frei
- Fulchiero, A.
- Fyeraband
- Gil
- Goldberg, I.
- Goldman, M.
- Gori, G.B.
- Grubner, O.
- Hayashi, M.
- Hayes, K.C.
- Hinds, W.
- Huber
- Hunt, R.
- Jenkins, R.
- Karnovsky, M.
- Kass, E.
- Kennedy
- Kochweser, S.
- Lage, A.
- Mahajan, V.
- Mcmillan, G.
- Meadow, H.C.
- Mead, J.
- Pochay
- Rabinowitz
- Reid, L.M.
- Roemer, H.C.
- Rubin
- Russell
- Sakuri
- Shea, J.
- Shinn, W.W.
- Sornberger, C.
- Spitzer, S.
- Stanford, L.E.
- Stclair, R.
- Stemerman, M.
- Stevens, A.J.
- Thurlbeck
- Tomasian, A.
- Trum, B.
- Weibel
- Weker, R.
- Wight
- Named Organization
- Aba Khoushy Medical School
- Adl, A.D.Little
- Ad Hoc Advisory Comm of Harvard Uni
- American Academy of Lab Sciences
- American Chemical Society
- American Federation for Clinical Re
- American Thoracic Society
- Angel Memorial Hospital
- Bat Hamburg Germany
- Belinson Hospital
- Beth Israel Hospital
- Boston City Hospital
- Bowman Gray School of Medicine
- British American Industries
- Channing Lab
- Charlesgate Animal Inhalation Lab
- Charlesgate West Realty
- Clinical Investigation Comm
- Dana Cancer Center
- Farber Inst
- Ford Foundation
- Harvard Univ
- Hew, Dept of Health Education and Welfare
- Imperial Tobacco Research Lab
- Long Island Chronic Disease Hospita
- Mass Inst of Tech
- Mattapan Chronic Disease Hospital
- Medical Planning Associates
- Meir General Hospital
- Mount Auburn Hospital
- Narragansett Brewery
- Natl Heart Lung + Blood Inst
- Natl Inst on Drug Abuse
- NCI, Natl Cancer Inst
- Niehs, Natl Inst of Environmental Health Sciences
- NIH, Natl Inst of Health
- Oak Ridge Natl Lab
- Palmetto Farms
- Peat Marwick Mitchell
- Pitney Bowes
- Prophet
- Pulmonary Function Lab
- Rambam Univ Hospital
- RJR, R.J.Reynolds
- Shattuck Chronic Disease Hospital
- Shb, Shook,Hardy & Bacon
- State Diagnostic Lab Ma
- St Vincent Hospital
- Technion
- Tel Aviv Univ
- Thorndike Lab
- Trans Natl Travel
- Tufts Univ
- US-Israel Binational Science Founda
- William B Castle Lab
- World Congress of Cardiology
- Recipient (Organization)
- Ad Hoc Advisory Comm of Harvard Uni
- Date Loaded
- 12 Feb 1999
- Copied
- Huber <Huber, G.L.>
- Characteristic
- MARG, MARGINALIA
- Litigation
- Stmn/Produced
- Site
- N14
- Master ID
- 03749906/0785
- 03749907
- 03749908-9910 Harvard Project Equipment
- 03749911-9912 Harvard Project Equipment
- 03749913-9915
- 03749916-9917 Harvard Project Equipment
- 03749918-9935 Tobacco Industry Equipment Inventory
- 03749936-9938 Harvard Project Equipment
- 03749939-9941 Harvard Project
- 03749942-9963 Compromise Agreement
- 03749964
- 03749965-9966
- 03749967-9970 Tentative Outline Tobacco Smoking and Pulmonary Disease
- 03749971
- 03749972-9973
- 03749974-9975 Harvard Project
- 03749976-9977 Exhibit A
- 03749988-0005 Compromise Agreement
- 03750006-0008 Harvard - Tobacco Companies Settlement
- 03750009-0010 Tobacco and Health Research Project
- 03750011-0012
- 03750013
- 03750014-0015
- 03750016-0017 Harvard Project Equipment
- 03750018-0023
- 03750024 Harvard Research Project
- 03750025
- 03750027
- 03750028
- 03750029
- 03750030-0032
- 03750033 Harvard
- 03750034-0035 Harvard Research Project
- 03750036
- 03750037-0047
- 03750049
- 03750050 Harvard Research Project
- 03750051-0052 Harvard Research Project
- 03750053
- 03750054
- 03750055-0056
- 03750057
- 03750059-0060
- 03750061 Gary Huber Research Equipment-Harvard Project
- 03750072-0073 Presentation of Smoking and Health Research Paper by Dr. Huber
- 03750074-0075 Harvard/Dr. Huber
- 03750076
- 03750077
- 03750078 Dr. Huber's Presentation
- 03750079-0081 $6 Million Granted for Smoking - Health Stu Dies
- 03750082-0083 Dr. Huber's Presentation
- 03750084 Presentation of Smoking and Health Research Paper by Dr. Huber
- 03750085 Harvard
- 03750086
- 03750090 Presentation of Smoking and Health Research Paper by Dr. Huber
- 03750091 Presentation of Smoking and Health Research Paper by Dr. Gary Huber
- 03750092
- 03750093 Presentation of Smoking and Health Research Paper by Dr. Gary Huber
- 03750094-0095
- 03750096
- 03750097-0098
- 03750099
- 03750100
- 03750112
- 03750113
- 03750114
- 03750115-0116
- 03750117
- 03750120
- 03750121-0123
- 03750124
- 03750125 General Bulletin to the Medical and Administrative Staffs
- 03750126-0127
- 03750128-0133
- 03750134
- 03750135-0136
- 03750137
- 03750138
- 03750139
- 03750140-0141 Sample Letter
- 03750142 Harvard University Faculty of Medicine Report of Professional Income
- 03750146
- 03750147
- 03750148
- 03750149-0150
- 03750151-0152
- 03750153
- 03750158
- 03750159-0160
- 03750161-0168 Clinical Ethics
- 03750169
- 03750170
- 03750171
- 03750172-0173
- 03750174-0175
- 03750176-0183 Dup of Id 03750161-0168
- 03750184-0185
- 03750186
- 03750187 Sin and Phin
- 03750189
- 03750190 Nicotine Titration Study
- 03750191
- 03750192-0193
- 03750194-0195
- 03750196
- 03750200
- 03750201-0202
- 03750203 Harvard Research Project
- 03750204-0206
- 03750207-0208
- 03750209-0210 Harvard Research Project
- 03750211-0212
- 03750213-0215 Harvard Smoking and Health Research Project
- 03750216-0217
- 03750218
- 03750219-0220
- 03750221
- 03750222 Pathology Space
- 03750223-0224
- 03750225-0226 Department of Pathology Laboratory
- 03750227
- 03750229 Personnel
- 03750230 Christine Segalla Termination
- 03750231 Speed Letter Christine Segalla - Termination
- 03750232-0233 Beth Israel Hospital Notice of Termination
- 03750234-0237 Harvard Smoking and Health Research Project
- 03750238
- 03750239-0240 Da-00566-05 Numerical Density of Secretory Cells
- 03750241
- 03750242
- 03750243-0255 Dean Tosteson and the Tobacco Industry
- 03750256-0258 Harvard Research Project
- 03750259
- 03750260
- 03750261
- 03750262-0263
- 03750264
- 03750265-0267
- 03750268 Harvard Research Project
- 03750269-0271 Harvard Smoking and Health Research Project
- 03750276-0282
- 03750372-0472 Seminars in Respiratory Medicine
- 03750473-0490 Undergraduate Cirricula in Respiratory Diseases A Regional Analysis of New England Medical Schools
- 03750548
- 03750549 Supplement A Appendices I - Xi
- 03750550 Appendix I
- 03750551-0555 Summary Tobacco Industry-Harvard University Meetings
- 03750556-0557
- 03750558-0560 Memorandum of Understanding
- 03750561-0562 (Appendix A) Approval Process for Protocols
- 03750563-0567 (Appendix B) Dr. Huber's Research Programs and Support
- 03750568 (Appendix C)
- 03750569-0570
- 03750571 Appendix C
- 03750572 Renovation Cost Estimate
- 03750573-0576
- 03750577 Appendix II
- 03750578-0580 Phaseout Costs of Tobacco Grant
- 03750581 Phaseout Costs of Tobacco Grant
- 03750582-0591 Termination Projections
- 03750592 Appendix III
- 03750593-0595 Dr. Gary Huber's Research Facilities
- 03750596 6 Charlesgate West Boston, Massachusetts
- 03750597 Appendix IV
- 03750598 Organizational Chart Harvard University Tobacco and Health Research Program
- 03750599
- 03750600-0601
- 03750602-0603
- 03750604-0605
- 03750606
- 03750607
- 03750608 Appendix V
- 03750609-0623 Speaking Manuscript Intestinal Parasites of the White Carneau Pigeon
- 03750624-0641 Speech Manuscript Some Normal Hematological Values of the White Carneau Pigeon
- 03750642 Intestinal Parasites of the White Carneau Pigeon
- 03750643 Some Normal Hematological Values of the White Carneau Pigeon
- 03750644 Appendix Vi
- 03750645-0647
- 03750648 Appendix I Technical Proposal for Program Extension
- 03750649-0650 Technical Proposal,Inhalation Bioassay of Cigarette Smoke in Pigeons Extended Protocol
- 03750651-0657 Appendix II Pigeon Population Projections
- 03750658-0669 Appendix III Pigeon Life Tables and Projected Animal Death Rates
- 03750670 Appendix IV Budget Projections
- 03750671 Contract Pricing Proposal
- 03750672-0673 Supplementary Budget
- 03750674 Appendix Vii
- 03750675
- 03750676-0681 Cardiovascular Effects of Cigarette Smoke
- 03750682 Acute Hemodynamic Effects of Cigarette Smoking in Man Assesed by Non-Invasive Technics
- 03750683-0704 Acute Hemodynamic Effects of Cigarette Smoking in Man Assessed by Non-Invasive Technics
- 03750705 Appendix Viii
- 03750706-0720 the Effect of Tobacco Nicotine Content on Cigarette Smoking Behavior in Man
- 03750721 the Effect of Tobacco Nicotine Content on Cigarette Smoking Behavior in Man
- 03750722-0723 Harvard Study Suggests Low Tar Cigarette Risk
- 03750724 Letter to the Editor Tar, Nicotine and Tobacco Smoking
- 03750725 'tar' May Be Down Lung Cancer Isn't
- 03750726-0728 Health Officials Fired Up Over 'tolerable ' Cigarettes
- 03750729 Dr. Gori's Ordeal
- 03750730-0733 Low-Risk Cigarettes: A Prescription
- 03750734 Dr. Gori's Crime: Truth
- 03750735-0736 Joint Statement
- 03750737-0738 Statement by Julius B. Richmond Surgeon General
- 03750739-0740 Less-Toxic Cigarette Stirs Controversy
- 03750741 Despite Study of Low-Tar Cigarettes, Surg Eon General Says None Is Safe
- 03750742 Killing the Messenger
- 03750743 'tolerable' Cigarettes?
- 03750744 Appendix Ix
- 03750745-0758
- 03750759 Appendix X
- 03750760-0761
- 03750762
- 03750763-0779 Harvard University Research Application to the American Petroleum Institute
- 03750780-0785 Appendix Xi
Related Documents:
Document Images
THE SECOND
REPORT TO THE AD HOC' ADVISORY COMMITTEE
OF'THE
HARUARD IJP!1 I VE RS I'IY
TOBACCO' AND' HEALTH RESEARCH PROGRAM!
December 15, 1'978'
GarX L. Huber, M. D.
Principal Investigator

TOBACCO ANDHEALTH RESEARCH PROGRAM
AD HOC ADVISORY COMMITTEE
Jere Mead,, M.D., Chairman.
Clifford A,, Barger, M. D.
Kurt J. Bloch, M.D.
Joseph,D. Brain, S'c.,D.,
Kenneth C'. Hayes, M.D.
5dward H. Kass, M. D'. , Ph, D'.,
Lynne M. Reid,, M.D.
.
I

TABLE 0F' COINiTENTS
I NTRODUCT ION
Ad'visory Committee Charge
ADMINISTRATIVE REPORT
Program Developments
History and Background
Harvard University-Tobacco Ind!ustry Support
Continued!Posiition of TobaccolIndustry Support
Potential Termination ofthe Tobacco:and Health Research Program
Harvard Medicaii Sehool~ Support
Potential Solutions to Facilities Development
Current Status of Relevant Decisions
Program FaciSities
- Present Research Facilities
- Will!iam B. Castle Laboratory
- Chariesgate Animal Inhalation Laboratory
- Facilities andlProgram Management
SCIENTIFIC REPORT
The Research Programi
- Personnel and Organization
- Personnel Changes,
Animal InhalationlProgram
- Smoking Machines
- Tobacco Smoke Chemistry and Physics
-
-
- Pigeon Inhalation Bioassay
Nicotine Analyses
Smoke Particulate Delivery
- Particle Size Measurements
-
-
- Response to Advisory Committee
Anticipated Research
Speciali Problems
Metabolism and Function:
- Alveolar Macrophage Function
- Metabolic and Enzymatic S'tudies C
- Alveolar Macrophage Subpopulations
Tobacco Investi
ations
- Other h'on j
g
- Ln
- Catalase Activity and Alveolar Macrophages O
- Response to Advisory Committee
- Anticipated Research W'
- Special Problems

Maerophage Morphology
Alveolar Macrophage Structure
Localization of Catalase inittie Alveolar Macrophage
Tobacco Smoke and Catallasomes
In situ Versus Lavage-Recovered Alveolar Macrophages
Alveolar Macrophages Recovered at Different Lavaging,Temperatures
Response to the Advisory Committee
Anticipated Research
Special Problems
Airway Mprphology
Airway Morphologic Studies
Rodent Pulmonary Infections
M'arij'uanaland Airway M'orphologic Studies
TobaccoiSmoke and the:Larynx
Response to the Advisory Committee
Anticipated Research
Special' Problems.
Parenchymal Morphology
- Tobacco Smoke andlEmphy:sema.
- Response to the Advisory Committee
- Anticipatedi Research
- Special Problems
Cardiovascular Effects of'Cigarette Smoke
- Direct Effect of Tobacco Smoke on Cardiac Muscle
- Experimental Atherogenesis
- Infection inithe Pigeon Quarters
- Research,on the Pathogenesis of Athexosclerosis
- Cigarette Smoking and Cardiovascular Function:in Man~
Response to the Advisory Committee
- Anticipated Research
- Sp cial Problems
Human Smoking Behavior
- Physiologic Studies on Human Smokers
- Nicotine Titration (Accommod'ation)' in
- Response to the Advisory Committee
- Anticipated Research
- Special Problems.
Biostatistics
- Biostatisti!cians
- Human Epid'emiologic Studies
- Morphometric Modeling
- Response to the Advisory Committee
- AnticipatedlResearch
- Special Problems
Human Smokers

OTHER CONSIDERATIONS~
- Federal Support.
- Budget Pro j ect iions and Expenditures
- Publications
Additional Perspectives

1.
INTRODUCTION

2.
TOBACCO AND HEALTH RESEARCH1 PROGRAM
Advisory Committee Charge: The Principal Investigator and Associate
Investigators in the Harvard University Tobacco and Health Research Program have
requested'that an ad hoc Advisory Committee,, formed of University faculty members
who are not directly associatediwith our research efforts or with the:Departments
in which our research is conducted,, evaluate on aniongoing basis the research
endeavors of the Program. The:charge of this Advisory Committee will' continue
to be to appraise our past accomplishments, our current research activities, andd
the direction of our anticipatedresearch, and on the basis of that assessment
to make recommendations directly to the administration of Harvard Medicall
School and to the participants of the Program in a manner that will help to
improve the~overall contribution of their efforts. It is our understanding that
the scope of the review will be confinedito the scientific and technical aspects
of o~urresearch i~ncludi'ng an evaluation of research~facillities andiadminis-
tration,, in accordance with the specific agreements and guiidelines signed
betweeniH'arvard Medical School and'the sponsoring organizations. In the:context
of those guid'elznes, the Principal Investigator and participating scientists of
the Tobacco and Health Research Program continue openly to welcome and encourage
criticism, suggestions and advice on program development and direetion., It is
anticipated that written recommendations will be made directly to the Principal~
Investigator, as welll a~s to the associate investigators and to that part of the
Harvard University administration directl~yrespons~iblefor the Program. I!tishoped that the
Adv:isory Committee will review periodically:the response of'the
research group to those recommendations.,
Our First Report on the Tobacco and Health Research Program was preparedion
January 30, 1978'. The ad hoc Advisory Committee first met with the Investigators
in the Program oniFebruary 1'.4, 1978 andl then again on March 13, 19:78 for an on-
si'te review of'the research facilities. The First Report of the ad hoc Advisory
Committee of the Harvard University Tobacco and Health Research Program was
submitted oniApri1 6, 1978. This Communication represents the Second Report of
the Investigators in the Program to the:Advisory Committee.
We have three goals for this Report. First, we have attemptedito review
the rather remarkable series of events andladmini:strative decisions that have
occurred since our last meeting with the!Advisory Committee, as they pertain
both to our research progress since that time and the current status of our
research endeavors. Second, we have included the rel'evant materialls that have
been compiled to reflect the development of a solution to the research, admin- ©
istrative, and facIlities needs of the Tobacco and Health Research Program. ~
Third, we again have reviewed specific research progress by individual areas of %P
scientific discipline, and in so doing have.incllud'ed both a summary of progress t-11
made on the recommendations developed by the Advisory Committee and anioutline
of' anticipated researchifor each section in the comi:ng months. We have al'so
tri'ed to identify any special problems inherent to each scientific Section of ~
the Harvardl University Tobacco and Health Research Program. We aill especially
look forward to the time when the efforts spent in future Reports to the Advisory
Committee will emphasize the third of these stated goals, hopefull'y:at the nearr
exclusion of the first two. That is not the calse,, however at this time.

The interim between the last meeting with the Advisory Committee and
the present has been a character building experience for the investigators,,
to say the least. In additionito the problems with laboratory and animali
facilities and research supporting resources,, we have hadito live from,
week-to-week, and then from month-to-month with indecision regazrding the
future of'the Program. This has resulted in functionall impairment to the
anticipated progression of academic careers during,what should be some of
the most investigativelly creative and productive years of the research
team. The effect of the present situation onithe personal lives of our
staff has not beeniinsignificant. Adjustment to these stresses and uncertainties
is within the realm of our human capacity for adaptation, and we as investi-
gators have been able to grow in many ways with some of these experiences.
The loss of the most important commod'ity we have, time, is much more d'i'ffi~;cul'tt
to reconcile, however.,
Considerable energies have been expended in an"attempt to find an
acceptable solution'for the Harvar&University Tobacco and Health Research,
Programi. The report by the Advisory Committee to the Program has been
crucially important and hellpful in the search for these solutions. The
administration of Harvard Medical School and the investigators in the
Program have tried to be responsive to the:guidance given1by the Advisory
Committee. We hope that continued assistance in this direction will be
provided and that the Committee wi1l be cogpisant of the response of the
Program to its input.
Our presentation of this Report to the Aduisory Committee is somewhat
arbitrarily divided into~twomajor sections: an ADMINISTRATIVE REPORT and
a! SCIENTIFIiC REPORT. Some thought and discussion were given to condensingg
the administrative section~ or to including the detailed information contained';
thereinias an appendage. Inithat the facilities and administrationio£ any
investigative program reflect its research potentiali, however,, and in that
the-conditions under which we have had to conduct our research effort over
the past year or more are not acceptable by any reasonable considerations,,
we have concl~uded that it is imp'ortant to identifyr and review again compre-
hensively our facilities and administrative need&.
It has taken much longer than anyone could have imagined to develop
options for continuation of'this Program. The potential solutions now
identified, although far fromiideali are acceptable. It is our hope that
the Advisory Committee will review the proposed solutions for providing,
adequate facilities to the Tobacco and Health Research Program with,the
same priority given to our research activities. All parties concerned will
welcome the!input of the Advisory Committee members in reaching final
recommendations to the granting,agencies.

4.
C
,
ADMINISTRATIVE REPORT
~

5.
C , P'ROGRAINi' DEVELOPMENTS
History and Background:Th~ehi'story and'.background of the:Harvard,Uni~versity
Tobacco andiHlealth Research Program were reviewed at length in the First Report
to the Advisory Committee., In summary, the:Program is supported'by a consortium~
of'cigarette manufacturing companies and tobacco growers and warehousemen, and
by indzvidual research grants and contracts from the Federal government., At
present, with all awarded funding implemented',, approximately 65% of the program
support is derivedifromindustrial sources andi 35a' from the National' Institutes
of' Health.If all of' our currently-approved grant and contract requests to~ the
Federa~l government could be implemented, the Program would'be supportedapproxi-
mately equally by NIH and1by tobacco industry sources.,
Harvard'U'niversity-Tobacco Industry Agreements: The initial and the
renewal agreements between the tobacco industry and HarvardlUniversity, as well
a~s all related important correspondence were submitted to the Advisory Committee~
as supplemental material to the First Report. It is a requirement of those
agreements that the Principal Investigator must provide the grantors with a
yearly report affirming that the agreements are being honored. Over the past
year,; we could not provide the grantors with those assurances, especially in
regardlto the entry in the Extension Agreement, implemented'lon July:1, 1977,
requiring the provision or arrangement by Harvard Medical School for adequate
housing,,services, and the like:for the Program., On that basis, as well as on
the basis of other problems identified in the First Report to the Advisory
Committee, the tobacco industry grantors withheld the semi-annual installment,,
in the amount of $311,A'07',, due Harvard University onJanuary 1, 1978, as well as
the semi-annual installment, in the amount of $'322,,075, due on July 1', 1978.
Thus,, the Program is currently approximately $'600,,000 in deficit spending, which
has been borne in total by HarvardlMedical School. Because of these events, as
well as the yet undetermined future of our Program, we have in addition not been
able to accept or implement significant new research support competitively
awardedlto our Program by the National Cancerr Institute.
Continued Position of Tobacco ZndustrySu.port: We have beeniin regular
communication1with our liaison to and the representatives of the tobaccoo
companies,, and they have consistently expressed their desire to continue support
for our research~program if acceptable facilities can be developed in which,to
house and to implement a scientifically objective research programirelatiye to
smoking,and health with,the goal' of providing major contributions toward the
solutionlof'some of the questions regarding cigarette smoking., A smalli com-
mittee:of industry-representatives was formed to evaluate the situation of the
Program at Harvard Uni:versity:. This committee consi'sted of Mr. Hi.C. Roemer,
Vice-President and GeneraL Counsel of R.J. Reynolds Industries, Inc., Arthur J.
Stevens,, V'ice-President and General Counsel of' Loril'.lard, a Di:visi'on of Loews
Theatres, Inc.,, William W. Shinn andiLeeE., Stanford, both, of' Sho~ok Hardy and
Bacon, the law office in Kansas Ci'ty that has served to consolidate~and com-
municate the tobacco industtry"s interests in the Harvard University Tobacco and
Health Research,Progr=.,
0301s05,e0
Following our request of'December 25, 1977, to the tobacco industry grantors
to provid'e supplementary suupport to improve our animal inhalation facilities,
which in our judgement are not of acceptable quality to perform the research,
for which weweTefunded, the industry committeescheduled' a visit to Boston on~
